Literature DB >> 21622969

Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis.

Denis Poddubnyy1, Martin Rudwaleit, Hildrun Haibel, Joachim Listing, Elisabeth Märker-Hermann, Henning Zeidler, Jürgen Braun, Joachim Sieper.   

Abstract

OBJECTIVE: To assess the progression of radiographic sacroiliitis in a cohort of patients with early axial spondyloarthritis over a period of 2 years and to explore predictors of progression.
METHODS: 210 patients with axial spondyloarthritis from the German Spondyloarthritis Inception Cohort have been selected for this analysis based on availability of radiographs at baseline and after 2 years of follow-up. Radiographs were centrally digitised and the sacroiliac joints were scored independently according to the grading system of the modified New York criteria for ankylosing spondylitis (AS) by two trained readers. The readers scored both time points simultaneously but were blinded for the time point and for all clinical data.
RESULTS: 115 patients (54.8%) fulfilled the modified New York criteria for AS in their radiographic part in the opinion of both readers at baseline, while 95 patients (45.2%) were classified as non-radiographic axial spondyloarthritis. More patients with non-radiographic spondyloarthritis (10.5%) compared with AS (4.4%) showed an estimated 'true' progression by at least one grade according to both readers, although the difference between the two groups was statistically non-significant. The rate of progression from non-radiographic axial spondyloarthritis to AS was 11.6% over 2 years. An elevated level of C-reactive protein (CRP) at baseline was a strong positive predictor of radiographic sacroiliitis progression in non-radiographic axial spondyloarthritis and AS (OR 3.65 and 5.08, respectively, p<0.05).
CONCLUSION: Progression of radiographic sacroiliitis by at least one grade after 2 years occurs only in a small percentage of patients with early axial spondyloarthritis. An elevated level of CRP was found to be a strong positive predictor of sacroiliitis progression.

Entities:  

Mesh:

Year:  2011        PMID: 21622969     DOI: 10.1136/ard.2010.145995

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  82 in total

Review 1.  Unmet Needs in Axial Spondyloarthritis.

Authors:  Ennio Lubrano; Antonia De Socio; Fabio Massimo Perrotta
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 2.  Axial spondyloarthritis: concept, construct, classification and implications for therapy.

Authors:  Philip C Robinson; Sjef van der Linden; Muhammad A Khan; William J Taylor
Journal:  Nat Rev Rheumatol       Date:  2020-12-23       Impact factor: 20.543

3.  [Early axial spondyloarthritis. Diagnostic approach and screening].

Authors:  D Poddubnyy; M Rudwaleit; J Sieper
Journal:  Z Rheumatol       Date:  2012-01       Impact factor: 1.372

Review 4.  Structural Disease Progression in Axial Spondyloarthritis: Still a Cause for Concern?

Authors:  Barbara Neerinckx; Rik J Lories
Journal:  Curr Rheumatol Rep       Date:  2017-03       Impact factor: 4.592

Review 5.  New evidence on the management of spondyloarthritis.

Authors:  Joachim Sieper; Denis Poddubnyy
Journal:  Nat Rev Rheumatol       Date:  2016-04-07       Impact factor: 20.543

6.  Patient Concerns and Perceptions Regarding Biologic Therapies in Ankylosing Spondylitis: Insights From a Large-Scale Survey of Social Media Platforms.

Authors:  Eldin Dzubur; Carine Khalil; Christopher V Almario; Benjamin Noah; Deeba Minhas; Mariko Ishimori; Corey Arnold; Yujin Park; Jonathan Kay; Michael H Weisman; Brennan M R Spiegel
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-02       Impact factor: 4.794

Review 7.  Spontaneous, drug-induced, and drug-free remission in peripheral and axial spondyloarthritis.

Authors:  Denis Poddubnyy; Lianne S Gensler
Journal:  Best Pract Res Clin Rheumatol       Date:  2014-11-10       Impact factor: 4.098

Review 8.  The ASAS Criteria for Axial Spondyloarthritis: Strengths, Weaknesses, and Proposals for a Way Forward.

Authors:  Sjef van der Linden; Nurullah Akkoc; Matthew A Brown; Philip C Robinson; Muhammad A Khan
Journal:  Curr Rheumatol Rep       Date:  2015-09       Impact factor: 4.592

Review 9.  Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?

Authors:  Chandra Mohan; Shervin Assassi
Journal:  BMJ       Date:  2015-11-26

10.  Changes of patient-reported outcomes and protein fingerprint biomarkers after exercise therapy for axial spondyloarthritis.

Authors:  Marketa Husakova; Anne Sofie Siebuhr; Karel Pavelka; Maja Spiritovic; Anne-Christine Bay-Jensen; Andrea Levitova
Journal:  Clin Rheumatol       Date:  2017-08-30       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.